1,4,6-Methenocyclobuta[gh]pyrrolizine(9CI) (68014-97-1)

Identification
Name:	1,4,6-Methenocyclobuta[gh]pyrrolizine(9CI)
Synonyms:	1,4,6-Methenocyclobuta[gh]pyrrolizine(9CI)
CAS:	68014-97-1
Molecular Formula:	C9H3N
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

1H-Pyrrolo[2,3,4-gh]pyrrolizine(9CI)
1,5-Methanoazirino[2,1,3-cd]benzo[gh]pyrrolizine(9CI)
5H-1,3-Dioxino[4,5,6-gh]pyrrolizine-5-methanol,hexahydro-4-hydroxy-2,2-dimethyl-, [3aS-(3aa,4b,5a,8aa,8ba)]- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,decahydro-4-hydroxy-3,4,5-trimethyl-, (8aR,13aR,13bR)- (9CI)
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methyl-, (3E,5S,6S,14aR,14bR)- (9CI)
Spiro[[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-3(2H),2'-oxirane]-2,7(4H)-dione,5,6,9,11,13,14,14a,14b-octahydro-6-hydroxy-4,5,6-trimethyl-,(2'S,4R,5R,6S,14aR,14bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(3R,4R,5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(5R,13aR,13bR)- (9CI)
7H-Pyrano[4',3':8,9][1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-4,7,10,14(5H)-tetrone,5a,8,9,9a,12,13,13a,16-octahydro-8,9,9a,13a-tetramethyl- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4-hydroxy-3,4,5-trimethyl-,(3R,4S,5S,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4,5-dihydroxy-5-(hydroxymethyl)- 4-methyl-3-(1-methylethyl)-,(3R,4R,5R,- 13aR,13bR)-
4-hydroxy-3,4,5-trimethyldecahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4-hydroxy-3,4,5-trimethyl-
2,4,6,7,7a,7b-hexahydrofuro[2,3,4-gh]pyrrolizine
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione,3-ethylidenedodecahydro-6-hydroxy-5,- 6-dimethyl-,(3E,5R,6R,9aS,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,13,14,14a-octahydro-6-hydroxy-5,6-dimethyl-,(3Z,5R,6R,14aR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7,13(9H)-trione,6-(acetyloxy)-3-ethylidene-3,4,5,6,14,14a-hexahydro-5,6-dimethyl-,(3Z,5R,6R,14aS)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14bdecahydro- 6-hydroxy-5,6-dimethyl-,(3Z,5S,- 6S,14aR,14bR)-
Adenosine 5'-(tetrahydrogen triphosphate),compounds,tetrasodium salt,mixt. with (3Z,5R,6R,9aS,14aR,14bR)-3-ethylidenedodecahydro- 6-hydroxy-5,6-dimethyl[1,6]- dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) and heparin